Skip to main content
XBI logo

State Street SPDR S&P Biotech ETF

XBINYSEARCAState StreetEquity

$145.88Today:−$4.67 (−3.10%)1Y +27.04%

As of Nov 16, 2026 close

Assets (AUM)
$10.19B
Expense ratio
0.35%
Dividend yield
0.37%
Holdings
166
52-week range
$113.06$169.89
Volume (live)
-
Avg. volume (3M)
9.68M

XBI ETF Holdings: State Street SPDR S&P Biotech ETF

The largest positions with their portfolio weights, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.

Total Holdings
166
Updated Oct 4, 2026
Top 10 Holdings
17.6%
Share of fund assets
Assets (AUM)
$10.19B
Total fund assets
Expense Ratio
0.35%
Annual management fee

Portfolio Allocations

Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.

Loading chart...

Top 52 of 166 XBI Holdings by Portfolio Weight

Holdings data last updated Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 52 positions.

Scroll to see more
XBI ETF holdings table showing rank, ticker symbol, company name, asset type, and portfolio weight percentage, sorted by portfolio weight, last updated Oct 4, 2026.
#SymbolNameTypeWeight
1
MRNA logo
MRNA
Moderna, IncStock2.81%
2
TWST logo
TWST
Twist Bioscience CorporationStock2.20%
3
NTRA logo
NTRA
Natera, Inc.Stock1.82%
4
IOVA logo
IOVA
Iovance Biotherapeutics, Inc.Stock1.59%
5
UTHR logo
UTHR
United Therapeutics CorporationStock1.57%
6
SYRE logo
SYRE
Spyre Therapeutics, Inc.Stock1.57%
7
ABBV logo
ABBV
AbbVie Inc.Stock1.54%
8
BIIB logo
BIIB
Biogen Inc.Stock1.53%
9
AMGN logo
AMGN
Amgen Inc.Stock1.51%
10
APGE logo
APGE
Apogee Therapeutics, Inc. Common StockStock1.50%
11
HALO logo
HALO
Halozyme Therapeutics, Inc.Stock1.50%
12
CRSP logo
CRSP
CRISPR Therapeutics AGStock1.49%
13
EXEL logo
EXEL
Exelixis, Inc.Stock1.47%
14
RVMD logo
RVMD
Revolution Medicines, Inc.Stock1.46%
15
GILD logo
GILD
Gilead Sciences, Inc.Stock1.46%
16
TGTX logo
TGTX
TG Therapeutics, Inc.Stock1.46%
17
VRTX logo
VRTX
Vertex Pharmaceuticals IncorporatedStock1.42%
18
PTGX logo
PTGX
Protagonist Therapeutics, Inc.Stock1.41%
19
KYMR logo
KYMR
Kymera Therapeutics, IncStock1.40%
20
GRAL logo
GRAL
GRAIL, Inc.Stock1.39%
21
PTCT logo
PTCT
PTC Therapeutics, Inc.Stock1.38%
22
KRYS logo
KRYS
Krystal Biotech, Inc.Stock1.36%
23
NBIX logo
NBIX
Neurocrine Biosciences, Inc.Stock1.35%
24
ALKS logo
ALKS
Alkermes plcStock1.35%
25
ORKA logo
ORKA
Oruka Therapeutics, Inc.Stock1.35%
26
MDGL logo
MDGL
Madrigal Pharmaceuticals, Inc.Stock1.34%
27
INCY logo
INCY
Incyte CorporationStock1.34%
28
PRAX logo
PRAX
Praxis Precision Medicines, IncStock1.34%
29
TVTX logo
TVTX
Travere Therapeutics IncStock1.30%
30
DNTH logo
DNTH
Dianthus Therapeutics Inc.Stock1.27%
31
CGON logo
CGON
CG Oncology, Inc. Common stockStock1.26%
32
ERAS logo
ERAS
Erasca IncStock1.23%
33
PCVX logo
PCVX
Vaxcyte, IncStock1.23%
34
REGN logo
REGN
Regeneron Pharmaceuticals, IncStock1.22%
35
INSM logo
INSM
Insmed IncorporatedStock1.22%
36
SRRK logo
SRRK
Scholar Rock Holding CorpStock1.18%
37
RYTM logo
RYTM
Rhythm Pharmaceuticals, IncStock1.14%
38
ROIV logo
ROIV
Roivant Sciences LtdStock1.12%
39
VKTX logo
VKTX
Viking Therapeutics IncStock1.09%
40
QURE logo
QURE
uniQure N.VStock1.08%
41
ARWR logo
ARWR
Arrowhead Pharmaceuticals, IncStock1.07%
42
RLAY logo
RLAY
Relay Therapeutics, IncStock1.07%
43
BMRN logo
BMRN
BioMarin Pharmaceutical IncStock1.07%
44
SLS logo
SLS
Sellas Life Sciences Group IncStock1.07%
45
ACAD logo
ACAD
ACADIA Pharmaceuticals IncStock1.06%
46
BBIO logo
BBIO
BridgeBio Pharma, IncStock1.04%
47
DYN logo
DYN
Dyne Therapeutics IncStock0.98%
48
CYTK logo
CYTK
Cytokinetics, IncorporatedStock0.97%
49
IMVT logo
IMVT
Immunovant IncStock0.97%
50
MIRM logo
MIRM
Mirum Pharmaceuticals IncStock0.96%
51
SMMT logo
SMMT
Summit Therapeutics PLCStock0.94%
52
CELC logo
CELC
Celcuity LLCStock0.93%

Source: Fund holdings disclosures. Last updated Oct 4, 2026. Data sources and methodology

Frequently Asked Questions About State Street SPDR S&P Biotech ETF Holdings

What are the top holdings in XBI?

In holdings data last updated Oct 4, 2026, XBI's largest holdings are Moderna, Inc (MRNA) at 2.81%, Twist Bioscience Corporation (TWST) at 2.20%, Natera, Inc. (NTRA) at 1.82%, Iovance Biotherapeutics, Inc. (IOVA) at 1.59% and United Therapeutics Corporation (UTHR) at 1.57%. Together these 5 positions make up 10.0% of the fund. XBI holds 166 securities in all; the holdings data lists the top 52 by weight.

How concentrated is XBI's portfolio?

In holdings data last updated Oct 4, 2026, the 10 largest of XBI's 166 positions make up 17.6% of assets. The largest single position is Moderna, Inc (MRNA) at 2.81%. The top 52 listed positions add up to 69.4%, so the remaining 114 holdings share 30.6%. Its largest sector, Healthcare, is 99.3% of the portfolio.

What is XBI's sector allocation?

In holdings data last updated Oct 4, 2026, XBI's largest sector weights are Healthcare (99.3%) and Financials (0.7%), together 100.0% of the portfolio. It has exposure to 2 sectors in total.

What countries does XBI invest in?

In holdings data last updated Oct 4, 2026, 96.6% of XBI's portfolio is invested in the United States, followed by the United Kingdom (1.4%), Switzerland (1.1%) and Netherlands (0.7%). XBI has exposure to 5 countries in total. By asset type the fund is 100.0% stocks.